Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W N Hait

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Cancer Communications|March 1, 1991
The role of the phorbol ester receptor/protein kinase C in the sensitivity of leukemic cells to anthracyclinesW N Hait, W T DeRosa
Clinical Research|April 1, 1991
The AFCR's public policy efforts--overview and outlookW N Hait, G F Schreiner
Biochemical Pharmacology|November 15, 1985
Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonistsW N Hait, G L Lee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Calmodulin: a potential target for cancer chemotherapeutic agentsW N Hait, J S Lazo
Cancer Investigation|January 1, 1988
Calmodulin as a target for new chemotherapeutic strategiesW N Hait, W T DeRosa
Life Sciences|January 28, 1985
Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulinG L Lee, W N Hait
Pharmacological Reviews|September 1, 1990
Pharmacology of drugs that alter multidrug resistance in cancerJ M Ford, W N Hait
The Yale Journal of Biology and Medicine|January 1, 1988
Potentiation of DNA damage and cytotoxicity by calmodulin antagonistsS A Rosenthal, W N Hait
Biochemical Pharmacology|January 9, 1992
Rational design and pre-clinical pharmacology of drugs for reversing multidrug resistanceW N Hait, D T Aftab
Cytotechnology|January 1, 1993
Pharmacologic circumvention of multidrug resistanceJ M Ford, W N Hait
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Cancer Communications|March 1, 1991
The role of the phorbol ester receptor/protein kinase C in the sensitivity of leukemic cells to anthracyclinesW N Hait, W T DeRosa
Clinical Research|April 1, 1991
The AFCR's public policy efforts--overview and outlookW N Hait, G F Schreiner
Biochemical Pharmacology|November 15, 1985
Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonistsW N Hait, G L Lee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Calmodulin: a potential target for cancer chemotherapeutic agentsW N Hait, J S Lazo
Cancer Investigation|January 1, 1988
Calmodulin as a target for new chemotherapeutic strategiesW N Hait, W T DeRosa
Life Sciences|January 28, 1985
Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulinG L Lee, W N Hait
Pharmacological Reviews|September 1, 1990
Pharmacology of drugs that alter multidrug resistance in cancerJ M Ford, W N Hait
The Yale Journal of Biology and Medicine|January 1, 1988
Potentiation of DNA damage and cytotoxicity by calmodulin antagonistsS A Rosenthal, W N Hait
Biochemical Pharmacology|January 9, 1992
Rational design and pre-clinical pharmacology of drugs for reversing multidrug resistanceW N Hait, D T Aftab
Cytotechnology|January 1, 1993
Pharmacologic circumvention of multidrug resistanceJ M Ford, W N Hait
Pageof 9